Head to head for first-timers
CoreAge Rx vs NuviaRx
CoreAge Rx and NuviaRx both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxNuviaRx
Rank #206 for first-timers · Grade C
Mama-Match
Best for: A mom who wants certainty she will not be charged without a prescription, and who reads the asterisk before the number.
Visit NuviaRxThe verdict for a first step
CoreAge Rx edges out NuviaRx on the Mama-Match Score, 94 to 51 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
NuviaRx is still a genuine option — "As low as $140/mo" with an asterisk — and for once the asterisk tells the truth: with the purchase of an annual plan. Month to month it is $214.95, and tirzepatide is $259.95 against the $170 advertised. That is 53% more on both, and it is disclosed rather than hidden. It also does something I have not seen anywhere else here: it holds your card instead of charging it, and only charges if a doctor writes the prescription. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | NuviaRx |
|---|---|---|
| Mama-Match Score | 94/100 · A | 51/100 · C |
| Overall rank | #1 | #206 |
| Semaglutide | $99/mo | $214.95/mo paying month to month |
| Tirzepatide | $149/mo | $259.95/mo paying month to month |
| Coverage | All 50 states | Not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
NuviaRx
Rank #206 · Grade C
What we like
- It holds rather than charges, and bills only after a doctor has reviewed and prescribed
- The asterisk beneath its headline price states the annual-plan condition outright
- All eight plan divisions, across both molecules, come out exact
The caveats
- The advertised figures are the annual tier; paying monthly costs 53% more
- ⛔ "Clinically proven 15-20% average weight loss" and "6+ inches waist reduction" have no source
- "Trusted by teams at over 1,000 of the world's leading organizations" is template text left on a prescription site, and it appears on the 404 page
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and NuviaRx with the other providers we review for women.
Or browse the full comparison hub.